Hao Liu1, Liang Liu2, Zhiyong Liu1, Qiang Li1, Chao You1, Jianguo Xu1. 1. Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China. 2. Department of Neurosurgery, Affiliated Hospital of Luzhou Medical College, Luzhou 646000, Sichuan Province, China.
Abstract
Craniopharynigoma samples were collected from 36 patients. Out of the 36 samples, 29 achieved successful sub-culturing, with a success rate of 80.6%. Immunohistochemistry staining showed that cytokeratin-7 was positively expressed in the cytomembrane and cytoplasm of craniopharyngioma cells at 6-8 passages, confirming that all cultured cells were squamous epithelial cells. The doubling time of craniopharyngioma cells was 3 days, as confirmed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. In this study, craniopharyngioma cells cultured in vitro were established; however, establishment of immortalized craniopharyngioma cell lines requires further research.
Craniopharynigoma samples were collected from 36 patients. Out of the 36 samples, 29 achieved successful sub-culturing, with a success rate of 80.6%. Immunohistochemistry staining showed that cytokeratin-7 was positively expressed in the cytomembrane and cytoplasm of craniopharyngioma cells at 6-8 passages, confirming that all cultured cells were squamous epithelial cells. The doubling time of craniopharyngioma cells was 3 days, as confirmed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. In this study, craniopharyngioma cells cultured in vitro were established; however, establishment of immortalized craniopharyngioma cell lines requires further research.
Entities:
Keywords:
cell line; craniopharyngioma; culture in vitro; cytokeratin-7; primary culture
Craniopharyngioma is a rare epithelium-derived tumor, located in the saddle area and arising along the path of the craniopharyngeal duct. The incidence of craniopharyngioma is reported as 0.13 per 100 000 persons per year[1], which accounts for 2-5% of all primary intracranial neoplasms[2] and 5.6-15% of intracranial tumors in children[3]. Most craniopharyngiomas are histologically benign tumors according to World Health Organization classification[4]. This tumor shows a bimodal age distribution: children aged 5-14 years and adults aged 50-74 years[356]. It has been reported that mortality after removal is as high as 45%, and that ten-year recurrence of craniopharyngioma is up to 90%[78]. Tumors are often located between the anterior optic chiasm and posterior mammillary body compressing important structures. Resection combined with radiotherapy and chemotherapy often leads to many vital complications[8]; therefore treatment of craniopharyngioma has been recognized as one of the most challenging subjects in the neurosurgical field. Recently, many studies on craniopharyngiomas have been conducted, although its pathogenesis and biological properties remain unclear[91011].Two main histological subtypes have been recognized, adamantineepithelioma tumors (AE) and squamous papillary tumors (SP), and transitional or mixed forms have also been ascribed to adamantine tumors[12].However, the lack of a cell line and animal model has limited basic research on craniopharyngiomas and impeded further investigations. Therefore, it is necessary to establish craniopharyngioma cell lines so that the morphology, differential growth, prognosis and effect of drug therapy on craniopharyngiomas can be observed in vitro and in vivo. This study sought to establish in vitro craniopharyngioma cell cultures, in a broader attempt to supply the theoretical foundation for the establishment of immortalized craniopharyngioma cell lines.
RESULTS
Success rate of different subtypes of craniopharyngioma cells
The continuous primary culture of craniopharyngioma cells was performed in 36 cases, in which 29 cases were successfully subcultured. The total success rate of subcultures was 80.6%. The success rate of AE cells (85.71%) was higher than that of SP cells (73.33%), but the difference was not significant (P > 0.05, Fisher's exact test; Table 1).
Table 1
Success rate of primary cultures of craniopharyngioma cells
Success rate of primary cultures of craniopharyngioma cells
Morphology of craniopharyngioma cells
After cells were cultured in vitro, the morphological characteristics of the two subtypes of craniopharyngioma cells were determined. Inverted contrast microscopy showed a similar morphology at early stages; craniopharyngioma cells were round, transparent and large in size. After adherence, two subtypes of craniopharyngioma cells appeared differently, and the size of SP cells was larger than AE cells. SP cells with an irregular polygon shape were linked tightly and exhibited fan-shape extensions at low densities (Figure 1A). AE cells were rhombus in shape and arranged typically like palisades. If the density of cells were low, cells were quadrigonal or pentagonal in shape (Figure 1B). The nuclei of AE cells were round and their size was large. Lipid droplets with rapid growth were occasionally found in the cytoplasm. There were often fibroblasts that were slender and spindle shaped in primary cultures, but the number of fibroblast cells decreased following continuous isolation and subculture.
Figure 1
Morphology of craniopharyngioma cells at the third passage (inverted contrast microscopy).
(A) Squamous papillary craniopharyngioma cells were alive on day 10 after subculture, showing a polygonal shape, low density and round or fan-shaped extensions (× 100).
(B) Adamantine epithelioma craniopharyngioma cells grew well on day 12 after subculture, with large nuclei and plentiful cytoplasm, presenting a slab stone-like arrangement (× 200).
Morphology of craniopharyngioma cells at the third passage (inverted contrast microscopy).(A) Squamous papillary craniopharyngioma cells were alive on day 10 after subculture, showing a polygonal shape, low density and round or fan-shaped extensions (× 100).(B) Adamantineepithelioma craniopharyngioma cells grew well on day 12 after subculture, with large nuclei and plentiful cytoplasm, presenting a slab stone-like arrangement (× 200).
Identification of craniopharyngioma cells by immunocytochemical staining
Expression of the cytokeratin-7 (CK7) antibody in tumor cells was detected by immunocytochemistry. CK7 protein was expressed in cytomembranes and the cytoplasm of craniopharyngioma cells. Therefore, the cultured cells could be considered squamous epithelium-derived cells[13] (Figure 2).
Figure 2
Expression of the cytokeratin-7 antibody in craniopharyngioma cells (× 200; inverted microscopy).
Expression of the cytokeratin-7 antibody in craniopharyngioma cells (× 200; inverted microscopy).(A) Passage 4 adamantineepithelioma craniopharyngioma cells expressing cytokeratin-7 immunoreactivity.(B) Passage 3 squamous epithelial craniopharyngioma cells expressing cytokeratin-7 immunoreactivity.
Growth characteristics of craniopharyngioma cells (Figures 3, 4)
The viability of craniopharyngioma cells was determined using trypan blue staining and the 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The doubling time of craniopharyngioma cells was 3.00 ± 0.35 days. Cell counts and activity significantly increased each day over 3 days in vitro (P < 0.05; Figures 3, 4).
Figure 3
Quantitation of adamantine epithelioma craniopharyngioma cells cultured in vitro (trypan blue count). The number of craniopharyngioma cells gradually increased during a period of 3-7 days.
Following inverted microscopy, viable cells were transparent and did not stain; dead cells were partially or completely stained blue. Cells from four squares of the counting card were counted using phase contrast microscopy (× 10).
The density of cells was calculated as follows: cell number/mL cell suspension = (the total number of cells in four squares/4) × 10 000 × dilution.
aP < 0.05, vs. the former day. Data are expressed as mean ± SD of four repeated experiments. Differences between groups were compared using one-way analysis of variance and the Student-Newman-Keuls test.
Figure 4
Viability of squamous papillary craniopharyngioma cells cultured in vitro (MTT assay). Absorbance was read at 490 nm using a spectrophotometer.
aP < 0.05, vs. the former day. Data are expressed as mean ± SD of four repeated experiments. Differences between groups were compared using one-way analysis of variance and the Student-Newman-Keuls test.
Quantitation of adamantineepithelioma craniopharyngioma cells cultured in vitro (trypan blue count). The number of craniopharyngioma cells gradually increased during a period of 3-7 days.Following inverted microscopy, viable cells were transparent and did not stain; dead cells were partially or completely stained blue. Cells from four squares of the counting card were counted using phase contrast microscopy (× 10).The density of cells was calculated as follows: cell number/mL cell suspension = (the total number of cells in four squares/4) × 10 000 × dilution.aP < 0.05, vs. the former day. Data are expressed as mean ± SD of four repeated experiments. Differences between groups were compared using one-way analysis of variance and the Student-Newman-Keuls test.Viability of squamous papillary craniopharyngioma cells cultured in vitro (MTT assay). Absorbance was read at 490 nm using a spectrophotometer.aP < 0.05, vs. the former day. Data are expressed as mean ± SD of four repeated experiments. Differences between groups were compared using one-way analysis of variance and the Student-Newman-Keuls test.
DISCUSSION
In total, 36 craniopharyngioma specimens were collected from inpatients with craniopharyngiomas at the Department of Neurosurgery, West China Hospital, China, including 21 AE cases and 15 SP cases.Cranipharyngioma cells were isolated and cultured by enzyme digestion and purified. It was proven that all investigated cells of each cell culture expressed CK7, which is a well-documented marker of craniopharyngioma cells irrespective of histological subtype[13].In this study, we attempted to develop primary cultures of craniopharyngioma cells from all 36 cases, however, only 29 succeeded in sub-culture. The success rate of adamantine tumors (85.71%) was higher than that of papillary tumors (73.33%), but the difference was not significant. When cell lines reached 6-8 passages, some craniopharyngioma cells were replaced by fibroblasts. There was a significant decrease in cell viability and cell lines failed to subculture. Craniopharyngioma cell growth activity was associated with the inoculation density of cells. The doubling time of craniopharyngioma cells was approximately 3 days. The survival time of cell cultures was approximately 12 weeks in vitro, and that of AE was often longer than SP. In addition, all craniopharyngioma cell lines could be frozen and resuscitated. CK7 protein was expressed in the cytomembrane and cytoplasm, indicating that cultured cell lines were squamous epithelial cells[13].To establish craniopharyngioma cell cultures, fresh tumor tissue is required and protecting the viability of cells is critical. Use of bipolar coagulators should be minimized during operation, and tumor specimens should be sent to the laboratory for culture as soon as possible. Primary cell cultures were established using native and mainly solid specimens that were captured immediately after surgical removal[14]. In addition, it is necessary to control the time of digestion. If digestion time is too long, cell viability will be compromised. If the digestion time is too short, cultures will take longer time to grow. As for serum, fetal bovine serum is optimal because it contains all kinds of growth factors and nutritional elements. Furthermore, keratinocyte medium with low concentrations of calcium ions keeps keratinized epithelial cells in their undifferentiated form, limiting the number of non-craniopharyngioma cells. In this study, the survival time of craniopharyngioma cells in vitro was different, ranging from 4 to 12 weeks. Their growth was slower than that of malignant tumors such as gliomas, and more rapid than that of benign tumors such as pituitary tumors. Therefore, the growth of craniopharyngiomas is intermediate, ranging between malignant and benign tumors. However, clinical manifestations of craniopharyngiomas are vicious with a high recurrence rate and mortality.Primary establishment of craniopharyngioma cell cultures is still challenging for researchers, because cell culture in vitro is unstable. So far, only three papers have been published regarding craniopharyngioma cell culture[11415]. These studies have shown that the growth of craniopharyngioma cells with high insulin-like growth factor-1 receptor (IGF-1R) expression could be inhibited by IGF-1R antagonists[1].Annet et al[14] applied SiRNA techniques to interfere with beta-catenin that had translocated into the nuclei in adamantineepithelioma craniopharyngioma cells, and found that the mobility of tumor cells was significantly reduced. Similarly, Annet et al[15] reported that activated epidermal growth factor receptor markedly promoted craniopharyngioma cell migration and invasion in vitro. However, no paper has specially reported on the establishment of primary craniopharyngioma cell culture. Cell models of craniopharyngiomas are the first step towards a detailed study of craniopharyngiomas.Craniopharyngioma cell culture can be used to study the biological behaviors of craniopharyngiomas, discover possible targets for drug therapies and to help understand the mechanisms of tumor progression. In conclusion, the primary cultures of craniopharyngioma cells established in this study will play an important role in future research of craniopharyngiomas.
MATERIALS AND METHODS
Design
A cytological controlled observation of cell culture in vitro.
Time and setting
Experiments were performed in the laboratory of the Department of Neurosurgery, West China Hospital, Sichuan University, China from February 2006 to March 2011.
Materials
Tumor specimen
Surgical specimens from 36 patients with craniopharyngiomas (20 males and 16 females; aged between 6 and 62 years old) were selected from West China Hospital, Sichuan University, China. Diagnosis was proven by imaging and histopathological findings from West China Hospital. Patients all underwent craniotomy and intraoperative frozen sections were prepared. Tumor tissues were diagnosed as craniopharyngiomas by two independent pathologists. In total, fresh tissues from 21 AE and 15 SP were identified, immediately stored in frozen conditions and taken to the laboratory for cell culture. All patients and/or their legal surrogates signed a written informed consent form. The experiments were authorized by the Ethics Committee of Medical Faculty of Sichuan University in China.
Inclusion criteria
(1) Patients had never previously been treated by radiotherapy, chemotherapy or both, and this was the first time they had received surgery. (2) The diagnosis of craniopharyngiomas and its subtypes was made by two independent pathologists. (3) Tumor maximal diameter was > 2 cm and there were no tumor residues after removal by magnetic resonance imaging (MRI).
Exclusion criteria
Patients who suffered from craniopharyngiomas and had been previously treated by radiotherapy, chemotherapy or both were not eligible.Patients were informed of the experimental scheme and risks before the enrollment in experiments, and gave informed consent according to the Administrative Regulations on Medical Institution, issued by State Council of China[16].
Methods
Primary culture of craniopharyngioma cells
Fresh tissue without necrosis was obtained under sterile conditions and put into Dulbecco's Modified Eagle Media: Nutrient Mixture F-12 (F12-DMEM) medium containing 10% (v/v) fetal calf serum, stored at 4°C in a container covered with ice cubes and immediately sent to the cell culture laboratory. Tissue was washed with phosphate-buffered saline (PBS) with penicillin and streptomycin, cut into pieces of 1-mm diameter, and placed into 50-mL centrifuge tubes. After digestion with 0.25% (w/v) trypsin for 20 minutes and centrifugation at 800 r/min for 3 minutes, F12-DMEM nutritive medium was used for cell suspension. After slight shaking, the trypan blue test was used to count cells. Cells were observed under an inverted microscope (type CKX41; Olympus, Tokyo, Japan). Viable cells were transparent and not stained, whereas dead cells were partially or completely stained blue. Cells in four squares in the counting card were counted using a phase-contrast microscope (10 ×). The density of cells was calculated as follows: cell number/mL cell suspension = (total number of cells in four squares/4) × 104 × dilution. Cells were then transferred into a 25-mL culture flask with 5 mL keratinocyte culture medium at density of 1-2 ×105 cells/mL. Culture flasks were kept at 37°C in a 5% CO2 atmosphere incubator.
Purification and subculture of craniopharyngioma cells
Fibroblasts were removed using silica gel, and craniopharyngioma cells were isolated by 0.025% (w/v) trypsin digestion and differential adhesion. After fibroblasts became round, culturing was terminated with 2 mL of serum-containing culture medium. Fibroblasts were triturated with a Pasteur pipette; cells were subcultured, and left to stand for 20 minutes; after some cells had adhered, the non-adherent cells and culture medium was transferred into another culture flask. After cells reached 80% convergence at the bottom of the culture flask, a titration pipette was used to collect the medium, and cells were digested for 1-2 minutes with 0.25% (w/v) trypsin. When cells contracted and appeared round under an inverted microscope, the trypsin was removed. Meanwhile, 10 mL of medium was added into the flask. After being washed repeatedly, the cell suspension was centrifuged at 1 000 r/min for 2-3 minutes. Cells were resuspended, transferred to a new culture flask, and placed in an incubator.
Storage of craniopharyngioma cells
Cells identified as craniopharyngioma cells were digested and centrifuged twice, and resuspended with 200 μL of medium containing 10% (v/v) dimethyl sulfoxide and 20% (v/v) fetal bovine serum. The culture medium was transferred into cryopreservation tubes after gentle shaking. Cells were stored at −20°C for 2 hours until the mixture was frozen. Then frozen cells were placed directly into a −70°C refrigerator for 24 hours, and deposited in −196°C liquid nitrogen.
Resuscitation of craniopharyngioma cells
Cryopreservation tubes containing tumor cells were taken out from liquid nitrogen, and placed swiftly into a 37°C water bath for resuscitating. When the cells had thawed, the tube was transferred into a sterile centrifugation tube and centrifuged at 1 000 r/min for 5 minutes. Next, cells were resuspended with F12-DMEM, counted and adjusted to a density of 1-2 ×105 cells/mL. Cells were maintained at 37°C in an incubator containing 5% CO2.
Identification of craniopharyngioma cells
Morphological observations: Cells subcultured onto 25-cm2 Petri dishes for 24 hours were found to adhere, and observed under an inverted phase contrast microscope (type CKX41; Olympus).Immunocytochemistry staining and the success rate of cell culture: CK7 was highly expressed in SP cells and hardly discovered in non-squamous epithelial cells. The expression of CK7 protein was detected by immunohistochemical staining (SP method) of CK7 (1:100). The primary antibody (mouse anti-humanCK7 monoclonal antibody; Cat MAB0166), UltraSensitive™ SP kit and DAB developer were bought from Fuzhou Maixin Biotechnology Development Co., Ltd., Fuzhou City, Fujian Province, China. The cytomembrane and cytoplasm were stained orange-brown, indicating CK7-immunoreactivity. Cells stained positive for CK7 were considered squamous epithelial cells. Five fields of vision were randomly selected under an inverted phase contrast microscope (200 × magnification; type CKX41; Olympus), with 100 cells in each field. Purification of primary cultured cell lines was over 90%.
Biological characteristics of craniopharyngioma cells
Cell growth was determined by the doubling time. A single cell suspension was produced using digestive enzymes and stained using Trypan blue. Using inverted phase contrast microscopy (Olympus), viable cells were bright and unstained, while unhealthy or dead cells were stained blue. Cells in four squares of the counting card were counted under an inverted microscope. The density of cells was calculated as follows: cell number/mL cell suspension = (the total number of cells in four squares/4) × 104 × dilution.Cell activity was measured using the MTT assay. Craniopharyngioma cells were seeded onto 96-well culture plates at 104 cells per well and maintained at 37°C in a 5% CO2 incubator for 3-5 days. 20 μL of MTT solution (5 mg/mL) was added into each well and cells were incubated at 37°C for 4 hours. The supernatant was removed, and each well was supplemented with 150 μL dimethyl sulfoxide and gently shaken for 10 minutes to dissolve the crystalline substrate.The absorbance values of each well were detected at 490 nm using a spectrophotometer (Beijing Hualian Ante Co., Ltd., China). The growth curve was plotted with time as the abscissa and the absorbance value of each well as the ordinate.
Statistical analysis
Statistical analysis was performed using SPSS 12.0 software (SPSS, Chicago, IL, USA). Continuous data are expressed as mean ± SD. The culture success rates of tumor cells were analyzed by the Fisher extract test. Cell counts and absorbance values were compared among subgroups using analysis of variance and Student-Newman-Keuls test. P < 0.05 was considered to be statistically significant (two-tailed).
Authors: Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee Journal: J Neuropathol Exp Neurol Date: 2002-03 Impact factor: 3.685
Authors: T Felton; G C Harris; S E Pinder; D R J Snead; G I Carter; J A Bell; A Haines; J Kollias; J F R Robertson; C W Elston; I O Ellis Journal: Breast Date: 2004-02 Impact factor: 4.380